Virus Delivery of CRISPR Guides to the Murine Prostate for Gene AlterationMaria Riedel 1, Martin F. Berthelsen 1, Latifa Bakiri 2, Erwin F. Wagner 2, Martin K. Thomsen 1
1Department of Clinical Medicine, Aarhus University, 2GDD, Cancer Cell Biology Program, National Cancer Research Center (CNIO)
This protocol describes a newly established method for virus delivery to the murine prostate. Using either CRISPR/Cas9 technology, gene overexpression, or Cre recombinase delivery, the technique allows orthotopic alteration of gene expression and implements a novel mouse model for prostate cancer.